Cancer-related gene expression profiles in NF1-associated pilocytic astrocytomas

Neurology

Volumn 56, Issue 7, 2001, Pages 885-890

  Li, Jun ^a   Perry, Arie ^a   James, C David ^b   Gutmann, David H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 4; EPIDERMAL GROWTH FACTOR RECEPTOR; NEUROFIBROMIN; PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROTEIN P16; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ADOLESCENT; ADULT; ARTICLE; ASTROCYTE; ASTROCYTOMA; CARCINOGENESIS; CHILD; CLINICAL ARTICLE; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NEUROFIBROMATOSIS; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION; WESTERN BLOTTING;

EID: 0035836665     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.56.7.885     Document Type: Article

References (27)

1. Natural history of optic pathway tumors in children with neurofibromatosis type 1: A longitudinal study
2. Optic pathway gliomas in children with neurofibromatosis 1: Consensus statement from the NF1 optic pathway glioma task force
3. Precocious puberty in children with neurofibromatosis type 1
4. Cerebellar astrocytomas. Part II. Pathologic features indicative of malignancy
5. The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins
6. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21
7. The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae
8. Regulators and effectors of ras proteins
9. Loss of neurofibromatosis 1 (NF1) gene expression in NF1-associated pilocytic astrocytomas
10. Loss of neurofibromin is associated with activation of ras/MAPK and PIS-K/akt signaling in a neurofibromatosis 1 astrocytoma
11. Malignant transformation of neurofibromas in neurofibromatosis 1 is associated with CDKN2A/p16 inactivation
12. The PEN5 epitope identifies an oligodendrocyte precursor cell population and pilocytic astrocytomas
13. A role for FISH detection of chromosome 22q dosage in distinguishing atypical teratoid/rhabdoid tumors from central PNET/medulloblastomas
14. Analysis of oncogene and tumor suppressor gene alterations in pediatric malignant astrocytomas reveals reduced survival for patients with PTEN mutations
15. National Institutes of Health Consensus Development Conference
16. Pilocytic astrocytoma
17. Combined activation of ras and akt in neural progenitors induces glioblastoma multiforme
18. High frequency of TP53 mutations in juvenile pilocytic astrocytomas indicates a role of TP53 in the development of these tumors
19. p53 gene mutations in human astrocytic brain tumors including pilocytic astrocytomas
20. Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects
21. Absence of p53 gene mutations in a tumor panel representative of pilocytic astrocytoma diversity using a p53 functional assay
22. Deletion of chromosome arm 17p DNA sequences in pediatric high-grade and juvenile pilocytic astrocytomas
23. Deletions of the INK4A gene occur in malignant peripheral nerve sheath tumors but not in neurofibromas
24. Refined mapping of 12q13-q15 amplicons in human malignant gliomas suggests CDK4/SAS and MDM2 as independent amplification targets
25. Signal transduction pathways and their relevance in human astrocytomas
26. Expression of PDGF and PDGF receptors in human astrocytoma operation specimens supports the existence of an autocrine loop